Skip to main navigation Skip to search Skip to main content

An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of Y-Clivatuzumab Tetraxetan plus Low-Dose Gemcitabine Versus Placebo plus Low-Dose Gemcitabine in Patients with Metastatic (Stage IV) Pancreatic Adenocarcinoma . . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/27/15 → 07/26/16

Funding

  • Immunomedics Incorporated: $14,500.00